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Background
The existence of an association between migraine and
thyroid diseases is still a matter of debate. Epidemiological
studies have shown a potential association between plasma
TSH concentrations and migraine but results are contra-
dictory. Subclinical hypothyroidism (SCH) is a common
clinical entity defined biochemically as a normal serum
free thyroxine (fT4) concentration in the presence of an
elevated serum thyroid-stimulating hormone (TSH) con-
centration. In population-based studies, the prevalence of
SCH ranges from 4 to 15 percent, the diagnosis being
more common in women and in old age. Prospective data
have shown that SCH is a risk factor for coronary heart
disease, heart failure, and cardiovascular mortality, prob-
ably related to a mechanism of endothelial dysfunction
and low grade chronic inflammation. A recent study
suggested an increased prevalence of subclinical hypothyr-
oidism in childhood migraine.
The purpose of this study was to evaluate the preva-
lence and clinical characteristics of migraine in patients
with subclinical hypothyroidism.
Methods
A case-control clinical study was conducted to investigate
the prevalence of migraine in 75 consecutive patients (66
females, 9 males; mean age ± SD: 52.8 ± 14.9 yrs) with
subclinical hypothyroidism and in 120 matched healthy
controls. Detailed information about migraine was
obtained using a structured questionnaire at a face-to-face
interview. Moreover, TSH, fT4, anti-thyroid peroxidase
antibody (TPO-ab), and anti-thyroglobulin (TG-ab) anti-
bodies were measured in SCH patients.
Results
The prevalence of lifetime migraine in SCH patients was
significantly higher than that in controls (62% vs 18%;
p < 0.001; odds ratio = 7.43; 95% confidence interval =
3.88-14.25). Percentage of migraine with aura versus
migraine without aura (MA/MO) was significantly higher
in SCH patients than controls (p = 0.03).
TSH, fT4, TPO-ab and TG-ab concentrations were not
significantly different between SCH patients with migraine
and without migraine.
Conclusions
Our data suggest that patients with subclinical hypothyr-
oidism have a higher risk of lifetime migraine than con-
trols. Additional studies are needed in order to confirm
this association and to investigate potential mechanisms of
this comorbidity.
Written informed consent to publication was obtained
from the patient(s).
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